Precigen hit positive operating cash flow a quarter ahead of its own target, with PAPZIMEOS net product revenue of $72.96 million. Second straight profitable quarter after a year of losses, and the EMA review plus pediatric development are the next catalysts.
Latest Activity
PGEN Coverage
3 Penny Stocks to Buy With $500
Are you interested in investing in penny stocks? Though doing so does come with risk, making the right investment decisions in the penny stock category can produce eye-opening returns. While the profits…
10% Owner Funds Trucking Acquisition, Plus More Big Insider Buying
A beneficial owner made a huge buy of shares in a trucking company this past week. That was not the only big insider buying though.